Rheumatoid Arthritis Patients Treated With Tocilizumab in Real Clinical Practice: Effectiveness and Safety (TRUST Study)
Phase of Trial: Phase IV
Latest Information Update: 08 May 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TRUST
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 08 May 2017 Results published in the Clinical and Experimental Rheumatology Journal.
- 21 Jun 2016 Time frame for primary endpoint changed from 2 years to 12 months.